MIRA INFORM REPORT

 

 

Report No. :

315122

Report Date :

04.04.2015

 

IDENTIFICATION DETAILS

 

Name:

TRANSASIA BIO-MEDICALS LIMITED

 

 

Formerly Known As :

TRANSASIA BIO-MEDICALS PRIVATE LIMITED

 

 

Registered Office :

Transasia House, 8, Chandivali Studio Road, Mumbai – 400072, Maharashtra

 

 

Country :

India

 

 

Financials (as on) :

31.03.2014

 

 

Date of Incorporation :

10.05.1985

 

 

Com. Reg. No.:

11-036198

 

 

Capital Investment / Paid-up Capital :

Rs. 40.000 Millions

 

 

CIN No.:

[Company Identification No.]

U33110MH1985PLC036198

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

MUMT00342G / MUMT09181E

 

 

PAN No.:

[Permanent Account No.]

AAACT2038C

 

 

Legal Form :

A Closely Held Public Limited Liability Company

 

 

Line of Business :

Manufacturer of Medical Equipments.

 

 

No. of Employees :

Not Available

 

 

RATING & COMMENTS

 

MIRA’s Rating :

A (63)

 

RATING

STATUS

PROPOSED CREDIT LINE

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

Fairly Large

 

Maximum Credit Limit :

USD 20800000

 

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having good track record.

 

Financial position of the company is sound. Fundamentals of the company are strong and healthy.

 

Trade relations are reported as fair. Business is active. Payment terms are reported to be regular and as per commitment.

 

The company can be considered normal for business dealings at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – December 31, 2014

 

Country Name

Previous Rating

(30.09.2014)

Current Rating

(31.12.2014)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

EXTERNAL AGENCY RATING

 

NOT AVAILABLE

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2014.

 

 

LOCATIONS

 

Registered/ Head Office :

Transasia House, 8, Chandivali Studio Road, Mumbai – 400072, Maharashtra, India

Tel. No.:

91-22-40309000/ 28575050/ 4040

Fax No.:

91-22-28573030

E-Mail :

transasia@transasia.co.in

transasia@vsnl.com

Website :

http://www.transasia.co.in

Location :

Owned

 

 

Manufacturing Units :

 

 

 

Unit 1 :

47/6, Gelwad Falia, Dhabhel, Nani Daman – 396210, Daman and Diu, India

 

 

Unit 2 :

B/11, OIDC Ringanwada, Nani Daman – 396210, India

 

 

Unit 3 :

SDF-VI, Unit No. 162, SEEPZ, Andheri (East), Mumbai – 400096, Maharashtra, India

 

 

Unit 4 :

SDF-VI, Unit No. 161, SEEPZ, Andheri (East), Mumbai – 400096, Maharashtra, India

 

 

Unit 5 :

Khasra Nos. 542, 543, 544 and 545, Village Malpur, District Solan, Badddi – 173205, Himachal Pradesh, India

 

 

Regional Offices :

Located at:

 

NORTH ZONE

·         New Delhi

·         Lucknow

·         Chandigarh

·         Jaipur

 

EAST ZONE

·         Kolkata

 

WEST ZONE

·         Mumbai

·         Pune

·         Ahmedabad

 

SOUTH ZONE

·         Bangalore

·         Chennai

·         Hyderabad

·         Cochin

 

CENTRAL ZONE

·         Patna

·         Indore

 

 

DIRECTORS

 

As on 30.09.2014

 

Name :

Mr. Suresh Hassanand Vazirani

Designation :

Managing director

Address :

Flat No. 3C, Mittal Paradise, Opposite Mittal Park, Off General Mhatre Marg, Juhu, Mumbai – 400072, Maharashtra, India

Date of Birth/Age :

15.07.1949

Qualification :

Diploma in Electrical Engineer

Experience :

25 Years

Date of Appointment :

18.12.2013

PAN No.:

AACPV8735D

DIN No.:

00122486

Other Directorship :

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U33110MH1985PLC036198

TRANSASIA BIO-MEDICALS LIMITED

Managing director

18-12-2013

10-05-1985

-

Active

NO

2

U33110MH1988PLC047094

TRANSASIA INSTRUMENTS LIMITED

Managing director

20-04-1988

20-04-1988

-

Active

NO

3

U33120MH1998PTC115943

SYSMEX INDIA PRIVATE LIMITED

Director

23-07-1998

23-07-1998

12-12-2008

Active

NO

4

U72100MH1999PTC120530

VAZIRANI PROPERTIES PRIVATE LIMITED

Managing director

25-06-1999

25-06-1999

-

Active

NO

5

U05000MH2003PLC080999

TAIPAN SEA FOODS LIMITED

Managing director

01-06-2007

01-06-2007

-

Active

NO

6

U93090MH2009PTC190680

SYSMEX TRANSASIA SERVICES PRIVATE LIMITED

Managing director

04-03-2009

04-03-2009

-

Active

NO

 

 

Name :

Mrs. Mala Suresh Vazirani

Designation :

Whole-time director

Address :

Flat No. 3C, Mittal Paradise, Opposite Mittal Park, Off General Mhatre Marg, Juhu, Mumbai – 400072, Maharashtra, India

Date of Birth/Age :

13.08.1958

Date of Appointment :

18.12.2013

PAN No.:

ABZPV1190L

DIN No.:

00122711

Other Directorship :

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U33110MH1985PLC036198

TRANSASIA BIO-MEDICALS LIMITED

Whole-time director

18-12-2013

01-12-1986

-

Active

NO

2

U33110MH1988PLC047094

TRANSASIA INSTRUMENTS LIMITED

Director

20-04-1988

20-04-1988

-

Active

NO

3

U72100MH1999PTC120530

VAZIRANI PROPERTIES PRIVATE LIMITED

Director

25-06-1999

25-06-1999

-

Active

NO

4

U05000MH2003PLC080999

TAIPAN SEA FOODS LIMITED

Director

01-06-2007

01-06-2007

-

Active

NO

 

 

Name :

Mr. Francis Matthew

Designation :

Director

Address :

209-D, Sheetal Apartments, Seven Bunglows, Andheri (West), Mumbai - 400053, Maharashtra, India

Date of Birth/Age :

10.07.1952

Date of Appointment :

01.12.1986

DIN No.:

00124796

Other Directorship :

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U33110MH1985PLC036198

TRANSASIA BIO-MEDICALS LIMITED

Director

01-12-1986

01-12-1986

-

Active

NO

2

U63040MH1990PTC056406

BUENAVISTA TRAVELS PRIVATE LIMITED

Director

03-05-1990

03-05-1990

-

Active

NO

3

U33110MH1988PLC047094

TRANSASIA INSTRUMENTS LIMITED

Director

21-01-2001

21-01-2001

-

Active

NO

4

U74900WB1956PTC007912

NEW INDIAN GLASS WORKS (CALCUTTA) PRIVATE LIMITED

Director

17-05-2007

17-05-2007

08-04-2010

Active

NO

5

U05000MH2003PLC080999

TAIPAN SEA FOODS LIMITED

Director

01-06-2007

01-06-2007

-

Active

NO

 

 

Name :

Ravi Hassanand Vazirani

Designation :

Director

Address :

1404, Meghdoot Alokhandwala Complex, Andheri (West), Mumbai – 400053, Maharashtra, India

Date of Birth/Age :

07.08.1962

Date of Appointment :

12.02.2014

DIN No. :

01995434

Other Directorship :

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U33110MH1985PLC036198

TRANSASIA BIO-MEDICALS LIMITED

Director

01-12-1986

01-12-1986

-

Active

NO

2

U63040MH1990PTC056406

BUENAVISTA TRAVELS PRIVATE LIMITED

Director

03-05-1990

03-05-1990

-

Active

NO

3

U33110MH1988PLC047094

TRANSASIA INSTRUMENTS LIMITED

Director

21-01-2001

21-01-2001

-

Active

NO

4

U74900WB1956PTC007912

New Indian Glass Works (Calcutta) Private Limited

Director

17-05-2007

17-05-2007

08-04-2010

Active

NO

5

U05000MH2003PLC080999

TAIPAN SEA FOODS LIMITED

Director

01-06-2007

01-06-2007

-

Active

NO

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 30.09.2014

 

Names of Shareholders

 

No. of Shares

Suresh Hassanand Vazirani

3359230

Mala Suresh Vazirani

640730

Nikhil Suresh Vazirani

10

Niharikaa Suresh Vazirani

10

Francis Matthew

10

Vibhuti Suresh Vazirani

10

Total

4000000

 

As on 30.09.2014

 

Equity Share Break up (Percentage of Total Equity)

 

Category

Percentage of Holding

Directors or relatives of Directors

100.00

Total

100.00

 

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of Medical Equipments.

 

 

Products :

Item Code No. (ITC Code)

Product Description

90278000

Parameter Fully Automated

Blood Cell Counter; Parameter Fully Automated Blood Cell Counter; Bio Chemistry Analyser EC 5 PLUSV2

 

 

Brand Names :

--

 

 

Agencies Held :

--

 

 

Exports :

--

 

 

Imports :

--

 

 

Terms :

--

 

PRODUCTION STATUS: NOT AVAILABLE

 

GENERAL INFORMATION

 

Suppliers :

Not Available

 

 

Customers :

Not Available

 

 

No. of Employees :

Not Available

 

 

Bankers :

·         HDFC Bank Limited

·         Royal Bank of Scotland N.V.

·         Kotak Bank

·         Indusind Bank

 

 

Facilities :

SECURED LOANS

31.03.2014

(Rs. In Millions)

31.03.2013

(Rs. In Millions)

LONG TERM BORROWINGS

 

 

Borrowing from government semi-government bodies

(First charge against all future movable properties.)

4.200

4.200

 

 

 

SHORT TERM BORROWINGS

 

 

Rupee term loans from banks

(The above facilities are secured by first paripassu charge in favour of RBS NV, HDFC Bank Limited, Barclays Bank PLC on entire current assets both present and future by way of hypothecation. Further in favour of Barclays Bank an exclusive charges on units of Debts oriented mutual funds having a value of at least 100% of the SBLC value by ways of pledge)

594.200

365.200

Working capital loans from banks

(The above facilities are secured by first paripassu charge in favour of RBS NV, HDFC Bank Ltd, Barclays Bank PLC on entire current assets both present and future by way of hypothecation. Further in favour of Barclays Bank an exclusive charges on units of Debts oriented mutual funds having a value of at least 100% of the SBLC value by ways of pledge)

709.400

455.500

Total

1307.800

824.900

 

Banking Relations :

--

 

 

Auditors :

 

Name :

Amit Vinay Chaturvedi

Chartered Accountants

Address :

714-715, Tulsiani Chambers, 212, Free Press Journal Marg, Nariman Point, Mumbai – 400021, Maharashtra, India

Income-tax PAN of auditor or auditor's firm :

AAAFC0662N

 

 

Memberships :

--

 

 

Collaborators :

--

 

 

Associate :

Sysmex Transasia Services Private Limited

 

 

Subsidiary Company :

·         Erba Diagnostics Mannheim Gmbh

·         Erba Diagnostics International B.V.

·         Erba Diasis Diagnostik Sistemler Ve Sanayi Ticaret A. S.

·         Erba Lachema s.r.o.

·         Erba Dignostics France

·         Erba Diagnostics Inc

·         Jas Diagnostics Inc

·         Diamedix Corporation

·         Erba RUS

·         Drew Scientific

·         Delta Biologicals S.R.L

 

 

Related Par

·         McSoft Infotech Private Limited

·         Taipan Sea Foods Limited

·         Transasia Engineers

 

 

CAPITAL STRUCTURE

 

As on 30.09.2014

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

4,000,000

Equity Shares

Rs.10/- each

Rs. 40.000 Million

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

4,000,000

Equity Shares

Rs.10/- each

Rs. 40.000 Million

 

 

 

 

 

FINANCIAL DATA

[all figures are in Rupees Million]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2014

31.03.2013

31.03.2012

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

40.000

40.000

40.000

(b) Reserves & Surplus

7244.900

5919.900

4801.600

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

7284.900

5959.900

4841.600

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

7.400

9.000

10.600

(b) Deferred tax liabilities (Net)

0.000

0.000

0.000

(c) Other long term liabilities

17.600

11.000

6.600

(d) long-term provisions

7.400

6.500

0.000

Total Non-current Liabilities (3)

32.400

26.500

17.200

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

1340.600

886.300

896.600

(b) Trade payables

532.100

522.500

504.800

(c) Other current liabilities

469.300

424.200

352.700

(d) Short-term provisions

122.900

149.400

172.300

Total Current Liabilities (4)

2464.900

1982.400

1926.400

 

 

 

 

TOTAL

9782.200

7968.800

6785.200

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

1346.000

1306.400

464.800

(ii) Intangible Assets

0.000

0.000

7.700

(iii) Capital work-in-progress

0.000

0.000

0.000

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

3781.400

2840.200

2551.900

(c) Deferred tax assets (net)

13.700

10.700

8.200

(d)  Long-term Loan and Advances

1588.800

1320.700

1282.400

(e) Other Non-current assets

7.500

36.100

33.800

Total Non-Current Assets

6737.400

5514.100

4348.800

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

105.200

0.000

10.000

(b) Inventories

899.100

737.500

695.000

(c) Trade receivables

1491.800

1413.500

1486.600

(d) Cash and cash equivalents

189.500

111.900

82.000

(e) Short-term loans and advances

352.700

189.900

158.100

(f) Other current assets

6.500

1.900

4.700

Total Current Assets

3044.800

2454.700

2436.400

 

 

 

 

TOTAL

9782.200

7968.800

6785.200

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2014

31.03.2013

31.03.2012

 

SALES

 

 

 

 

 

Income

4725.900

4115.400

3646.900

 

 

Other Income

218.200

194.800

125.000

 

 

TOTAL                                     (A)

4944.100

4310.200

3771.900

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost of Materials Consumed

718.400

670.700

568.100

 

 

Purchases of Stock-in-Trade

1189.300

1032.500

1069.100

 

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

(118.200)

(84.800)

(152.500)

 

 

Employees benefits expense

651.100

486.600

430.400

 

 

Other expenses

669.200

641.000

612.900

 

 

TOTAL                                     (B)

3109.800

2746.000

2528.000

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)     (C)

1834.300

1564.200

1243.900

 

 

 

 

 

Less

FINANCIAL EXPENSES                                    (D)

49.800

50.800

58.000

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                               (E)

1784.500

1513.400

1185.900

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

202.800

158.600

114.300

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX (E-F)                (G)           

1581.700

1354.800

1071.600

 

 

 

 

 

Less

TAX                                                                  (H)

224.500

178.500

145.900

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX (G-H)                  (I)

1357.200

1176.300

925.700

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

FOB value of export

550.900

527.900

457.800

 

 

Interest Income

13.300

11.100

11.800

 

TOTAL EARNINGS

564.200

539.000

469.600

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Raw Materials

458.000

324.800

 

 

 

Finished goods and Capital Goods

966.200

924.600

 

 

 

Travelling Expenses

21.600

25.300

 

 

TOTAL IMPORTS

1445.800

1274.700

1183.300

 

 

 

 

 

 

Earnings / (Loss) Per Share (Rs.)

339.00

294.09

230.79

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2014

31.03.2013

31.03.2012

Net Profit Margin

(PAT/Sales)

(%)

28.72

28.58

25.38

 

 

 

 

 

Operating Profit Margin

(PBDIT/Sales)

(%)

38.81

38.01

34.11

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

26.42

26.47

25.36

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.22

0.23

0.22

 

 

 

 

 

Debt Equity Ratio

(Total Debt/Networth)

 

0.19

0.15

0.19

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.24

1.24

1.26

 


 

FINANCIAL ANALYSIS

[all figures are in Rupees Million]

 

DEBT EQUITY RATIO

 

Particular

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Share Capital

40.000

40.000

40.000

Reserves & Surplus

4801.600

5919.900

7244.900

Net worth

4841.600

5959.900

7284.900

 

 

 

 

long-term borrowings

10.600

9.000

7.400

Short term borrowings

896.600

886.300

1340.600

Total borrowings

907.200

895.300

1348.000

Debt/Equity ratio

0.187

0.150

0.185

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Sales

3646.900

4115.400

4725.900

 

 

12.847

14.835

 

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Sales

3646.900

4115.400

4725.900

Profit

925.700

1176.300

1357.200

 

25.38%

28.58%

28.72%

 

 


 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

No

9]

Name of person contacted

No

10]

Designation of contact person

No

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

-----

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

No

20]

Export / Import details (if applicable)

No

21]

Market information

-----

22]

Litigations that the firm / promoter involved in

-----

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

-----

26]

Buyer visit details

-----

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

Yes

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

No

 

 

INDEX OF CHARGES

 

S.NO.

CHARGE ID

DATE OF CHARGE CREATION/MODIFICATION

CHARGE AMOUNT SECURED

CHARGE HOLDER

ADDRESS

SERVICE REQUEST NUMBER (SRN)

1

10496177

21/05/2014

100,000,000.00

CITI BANK N.A.

FIFC PLOT NOS. C-54 & C-55, G-BLOCK, BANDRA KURLA, 
COMPLEX, G-BLOCK, BANDRA (EAST), MUMBAI, MAHARASHTRA - 400051, INDIA

C04903571

2

10440922

14/10/2014 *

400,000,000.00

KOTAK MAHINDRA BANK LIMITED

27BKC, C 27, G BLOCK, BANDRA KURLA COMPLEX, BANDRA (EAST), MUMBAI, MAHARASHTRA - 400051, INDIA

C30954200

3

10345344

05/03/2012

15,391,000.00

DEPARTMENT OF BIOTECHNOLOGY

6-8TH FLOOR, BLOCK NO. 2, CGO COMPLEX,LODHI ROAD, NEW DELHI, DELHI - 110003, INDIA

B36198968

4

10072790

01/12/2011 *

420,000,000.00

HDFC BANK LIMITED

HDFC BANK HOUSESENAPATI BAPAT MARG, LOWER PAREL WEST, MUMBAI, MAHARASHTRA - 400013, INDIA

B27380906

5

10051810

21/10/2011 *

160,000,000.00

THE ROYAL BANK OF SCOTLAND N V

HANSALAYA BUILDING, 15, BARAKHAMBA ROAD, NEW DELHI, DELHI - 110001, INDIA

B23831134

6

90215716

28/03/2001

50,000,000.00

ICICI BANK LIMITED

ICICI TOWERS, BANDRA KURLA, MUMBAI, MAHARASHTRA, 
INDIA

-

7

90215696

18/09/2000

118,000,000.00

ICICI BANK LIMITED

215; FREE PRESS HOUSE, NARIMAN POINT, MUMBAI, MAH 
ARASHTRA, INDIA

-

8

90215401

25/09/1995 *

3,000,000.00

UNION BANK OF INDIA

INDUSL. FINANCE BRANCH, 239; VIDHAN BHAWAN; NARIM 
AN POINT, MUMBAI, MAHARASHTRA - 400021, INDIA

-

9

90215300

16/10/1991

11,500,000.00

INDIAN BANK

210; MITTAL TOWERS, MUMBAI, MAHARASHTRA, INDIA

-

10

90215294

20/08/1991

169,800.00

INDIAN BANK

210; MITTAL TOWER, NARIMAN POINT, MUMBAI, MAHARAS 
HTRA - 400021, INDIA

-

11

90215138

24/01/1988

3,375,000.00

INDIAN BANK

OSHIWARA BRANCH, MUMBAI, MAHARASHTRA - 400008, INDIA

-

 

* Date of charge modification

 

UNSECURED LOANS

 

PARTICULAR

31.03.2014

(Rs. In Million)

31.03.2013

(Rs. In Million)

LONG TERM BORROWINGS

 

 

Borrowing from government semi-government bodies

(Interest free Term loan of Rs 80 Lacs from National Research Development Corporation under Ministry of Science and Tech., of Government of India, repayable in 5 (Five) equal yearly installment of Rs 1.600 Million starting from 31st March 2012. Grant in the form of Term loan of Rs 14.000 Million, out of which first installment of Rs 4.200 Million received from Department of Biotechnology, Govt Of India (DBT) for funding support under the Biotechnology Industry Partnership Programmed (BIPP) of The DBT, repayable in 10 (ten) equal half yearly installments of Rs 1.400 Million each starting from April 2015.)

3.200

4.800

 

 

 

SHORT TERM BORROWINGS

 

 

Loans and advances from directors

17.100

47.100

Other loans and advances, others

19.900

18.500

Total

40.200

70.400

 

 

OPERATIONS AND PERFORMANCE REVIEW

 

The company has continued on its growth path registering an increase in the overall turnover by 14.83% and Profit before Tax by 16.74%. Your company continues to hold for yet another year a major market share in market segments like Haematology, Biochemistry (Routine Chemistry Reagents) and Critical Care Electrolytes.

 

 

CONTINGENT LIABILITIES:

 

PARTICULARS

31.03.2014

(Rs. In Millions)

31.03.2013

(Rs. In Millions)

i) Corporate guarantees given for issue of SBLC by banks on behalf of its subsidiary

1987.600

1906.900

ii) Corporate guarantees issued by the Company to banks on behalf of Subsidiaries and other

176.500

0.000

iii) Claims against the Company not acknowledged as debts

10.100

8.500

iv) Bank Guarantees issued

78.100

76.700

Total

2252.300

1992.100

 

 

FIXED ASSETS

 

Tangible Assets

·         Land

·         Buildings

·         Plant and Machinery

·         Computers

·         Electric and Office Equipment’s

·         Furniture and Fixtures

·         Motor Cars

·         Instruments at Customers Site


 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.62.59

UK Pound

1

Rs.92.46

Euro

1

Rs.67.51

 

 

INFORMATION DETAILS

 

Analysis Done by :

DIV

 

 

Report Prepared by :

MRI

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

7

PAID-UP CAPITAL

1~10

7

OPERATING SCALE

1~10

7

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

7

--PROFITABILITY

1~10

7

--LIQUIDITY

1~10

7

--LEVERAGE

1~10

7

--RESERVES

1~10

7

--CREDIT LINES

1~10

7

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

63

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.